Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection.

MLA

Chariyavilaskul, Pajaree, et al. “Pharmacokinetics of Sofosbuvir/Velpatasvir and Efficacy of an Alternate‐day Treatment in Hemodialysis Patients with Chronic Hepatitis C Infection.” CTS: Clinical & Translational Science, vol. 17, no. 7, July 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1111/cts.13884.

APA

Chariyavilaskul, P., Prompila, N., Wittayalertpanya, S., Lekhyananda, S., Prasithsirikul, W., Trakarnvanich, T., Jeenapongsa, S., Susantitaphong, P., Kerr, S., Avihingsanon, A., Tangkijvanich, P., & Praditpornsilpa, K. (2024). Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection. CTS: Clinical & Translational Science, 17(7), 1–12. https://doi.org/10.1111/cts.13884

Chicago

Chariyavilaskul, Pajaree, Nantaporn Prompila, Supeecha Wittayalertpanya, Sookruethai Lekhyananda, Wisit Prasithsirikul, Thananda Trakarnvanich, Somboon Jeenapongsa, et al. 2024. “Pharmacokinetics of Sofosbuvir/Velpatasvir and Efficacy of an Alternate‐day Treatment in Hemodialysis Patients with Chronic Hepatitis C Infection.” CTS: Clinical & Translational Science 17 (7): 1–12. doi:10.1111/cts.13884.